Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Fisher

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The European Respiratory Journal|September 4, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Annals of the Rheumatic Diseases|September 5, 2025
ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung diseaseKaterina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Trials|July 17, 2019
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocolMariam Al-Laith, Marianna Jasenecova, Sonya Abraham, et al.
Med (New York, N.Y.)|June 1, 2022
Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseasesIlya Korsunsky, Kevin Wei, Mathilde Pohin, et al.
Nature Reviews. Rheumatology|January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Autoimmunity Reviews|November 9, 2018
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysisRoberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
Annals of the Rheumatic Diseases|June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
Seminars in Arthritis and Rheumatism|February 4, 2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generationRachael A Gordon, Yann Nguyen, Nathan Foulquier, et al.
Nature Reviews. Rheumatology|June 10, 2025
2023 International Rome consensus for the nomenclature of Sjögren diseaseManuel Ramos-Casals, Alan N Baer, María Del Pilar Brito-Zerón, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The European Respiratory Journal|September 4, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Annals of the Rheumatic Diseases|September 5, 2025
ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung diseaseKaterina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Trials|July 17, 2019
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocolMariam Al-Laith, Marianna Jasenecova, Sonya Abraham, et al.
Med (New York, N.Y.)|June 1, 2022
Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseasesIlya Korsunsky, Kevin Wei, Mathilde Pohin, et al.
Nature Reviews. Rheumatology|January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Autoimmunity Reviews|November 9, 2018
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysisRoberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
Annals of the Rheumatic Diseases|June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
Seminars in Arthritis and Rheumatism|February 4, 2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generationRachael A Gordon, Yann Nguyen, Nathan Foulquier, et al.
Nature Reviews. Rheumatology|June 10, 2025
2023 International Rome consensus for the nomenclature of Sjögren diseaseManuel Ramos-Casals, Alan N Baer, María Del Pilar Brito-Zerón, et al.
Pageof 9